Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Neuroendocrine Tumors Clinical Trials
Neuroendocrine Tumors clinical trials are recruiting across 113 cities. Here are the cities with the most active studies:
Neuroendocrine Tumors Trial Phases
61 research organizations are sponsoring neuroendocrine tumors trials.
About Neuroendocrine Tumors
Neuroendocrine tumors (NETs) develop from hormone-producing cells and can occur in many organs, most commonly the gastrointestinal tract and lungs. They range from slow-growing to aggressive. Treatment includes surgery, somatostatin analogs, targeted therapy, and peptide receptor radionuclide therapy.
Clinical trials are advancing new treatments for neuroendocrine tumors. Currently, 85 studies are recruiting a combined 2,258,365 participants across the United States. Research is being conducted by 61 organizations including Helix, Inc, Rady Pediatric Genomics & Systems Medicine Institute, Columbia University and 58 others.
2026 Neuroendocrine Tumors Research Landscape
As of July 2026, the neuroendocrine tumors clinical trial landscape includes 85 actively recruiting studies across 113 cities in the United States. These studies are collectively seeking 2,258,365 participants, with an average enrollment target of 26,569 per study.
The research spans multiple phases of development: 26 studies are in PHASE2, 18 studies are in PHASE1, 16 studies are in NA, 8 studies are in PHASE3, 3 studies are in PHASE4. The presence of Phase 3 trials indicates that some neuroendocrine tumors treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 61 different organizations, including Helix, Inc, Rady Pediatric Genomics & Systems Medicine Institute, Columbia University, National Human Genome Research Institute (NHGRI), National Cancer Institute (NCI), and 56 others. The large number of sponsors reflects significant research interest and investment in neuroendocrine tumors treatment advancement.
Geographically, neuroendocrine tumors trials are most concentrated in Bethesda, Maryland (14 trials); Miami, Florida (9 trials); New York, New York (8 trials); Los Angeles, California (8 trials); Washington D.C., District of Columbia (8 trials) and 7 other cities.
Featured Neuroendocrine Tumors Studies
Highlighted recruiting studies for neuroendocrine tumors, selected by enrollment size and research scope.
Helix Research Network
The Helix Research Network ("HRN") is a network of academic, public, and/or private healthcare organizations that are committed to advancing medical research and improving human health through large-scale genomics research and acceleration of the integration of genomic and other omics data into clinical care.
Rady Children's Institute Genomic Biorepository
Rady Children's Institute for Genomic Medicine (RCI) will collect biological samples (such as blood), derived genomic sequences (from DNA and RNA), and clinical features in a Biorepository as a standardized resource for future research studies. The purpose of the Genomic Institute Biorepository is to provide consented samples and data for basic and clinical research related to the genomic cause an...
Genomic Uniformed-Screening Against Rare Disease In All Newborns
The goal of this study is to learn how genomic sequencing technology can be used to effectively expand the conditions screened on newborn screening. Newborn screening ensures equity and allows all babies to have the same chance at the healthiest life. Families will be invited to have their newborn baby screened for additional conditions beyond what all babies are screened for as part of the newbor...
Frequently Asked Questions About Neuroendocrine Tumors Clinical Trials
Are there neuroendocrine tumors clinical trials near me?
Yes, there are 85 neuroendocrine tumors clinical trials currently recruiting across 113+ cities in the United States, including Bethesda, Maryland; Miami, Florida; New York, New York. Browse the studies above to find one at a location convenient for you.
How do I join a neuroendocrine tumors clinical trial?
To join a neuroendocrine tumors clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are neuroendocrine tumors clinical trials free?
Yes, participation in neuroendocrine tumors clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of neuroendocrine tumors treatments are being studied?
Current neuroendocrine tumors clinical trials are testing a range of approaches across PHASE2 (26 studies), PHASE1 (18 studies), NA (16 studies), PHASE3 (8 studies), PHASE4 (3 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 61 research organizations.
Is it safe to participate in neuroendocrine tumors clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 17, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 17, 2026 · Data from ClinicalTrials.gov